U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 11 - 11 of 11 results

ALBUCA BRACTEATA WHOLE

MORE DETAILS

GK156DX76Z

structurally diverse
Status:
Possibly Marketed Outside US
Source:
21 CFR 347
(2018)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6855c562-ecdb-5e82-e053-2a91aa0a2d40
First approved in 2018
Source:
21 CFR 347
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6855c562-ecdb-5e82-e053-2a91aa0a2d40
Class:
STRUCTURALLY DIVERSE

Showing 11 - 11 of 11 results

NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966